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Abstract Nerve growth factor (NGF), the prototypic member
of the neurotrophin family of growth factors, exerts its action via
two receptors, P75NTR and TrkA, the expression of which varies
at the cell surface of neuroblastoma cells (SH-SY5Y cells) in a
cycle phase-specific manner. NGF was pro-apoptotic on growing
cells expressing preferentially P75NTR and exhibited a potent
anti-apoptotic effect on quiescent cells, when TrkA was prevalent
at the cell surface, showing that NGF can have a dual action on
SH-SY5Y cells depending on the relative cell surface expression
of TrkA and P75NTR. The pro-apoptotic activity of NGF but not
its anti-apoptotic activity was abrogated by an antibody against
the extracellular domain of P75NTR and in cells isolated from
P75NTR knock-out mice indicating that NGF exhibits a pro-
apoptotic activity via P75NTR exclusively. On the other hand, we
showed that the anti-apoptotic activity of NGF was specifically
mediated by an interaction with TrkA with no contribution of
P75NTR, as demonstrated on SK-N-BE cells transfected with
TrkA in which NGF was a potent anti-apoptotic compound but
did not exhibit any pro-apoptotic activity. These results support
the hypothesis that the survival response to NGF depends on its
binding to TrkA without any involvement of P75NTR which in
turn selectively mediates the pro-apoptotic activity of NGF with
no contribution of TrkA and show that, depending on the growth
state of the cells, NGF exhibits dual pro- or anti-apoptotic
properties via P75NTR and TrkA, respectively.
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1. Introduction
Nerve growth factor (NGF) is a member of a structurally
and functionally related family of proteins (termed neurotro-
phins) with pleiotropic roles [1], including critical functions in
the development, survival and di¡erentiation of neurons [2^9].
The action of NGF is mediated by two classes of cell surface
receptors: TrkA [10,11], a member of the Trk family of tyro-
sine kinase receptors, and P75NTR, a low a⁄nity receptor that
also binds other neurotrophins such as BDNF or NT-3
[12,13]. The role of P75NTR in the functional response to
NGF is still controversial [14,15]. Some reports indicate that
P75NTR collaborates with TrkA in the formation of high-af-
¢nity binding sites and in NGF signal transduction [16^19],
but others suggest that TrkA alone may be su⁄cient to sup-
port the activity of NGF on cell di¡erentiation [20]. P75NTR
also possesses unique, Trk-independent signalling properties
which involve ceramide production [21] and activation of
the transcription factor NFUB [22]. Moreover, recent evidence
indicates that NGF uses a two-receptor system to dictate sig-
nalling pathways leading to either cell survival or suicide, but
this topic has been a continuing source of controversy [23^25].
Recently, Urdiales et al. [26] showed that TrkA was expressed
preferentially at the cell surface in the early G1 and M phases
of the cell cycle whereas P75NTR was only detectable during
the late G1, S and G2 phases.
These observations led us to examine the e¡ect of NGF on
the apoptotic response of SH-SY5Y, a neuroblastoma cell
line, and to evaluate the respective roles of TrkA and
P75NTR in the pro- and anti-apoptotic activities of NGF.
2. Materials and methods
2.1. Materials
The human neuroblastoma cell line SH-SY5Y was kindly provided
by Dr D. Caput (Sano¢ recherche, Labe'ge, France). Dulbecco’s modi-
¢ed Eagle medium (DMEM), RPMI 1640 medium, geneticin, genta-
micin, pyruvate, anti-PPLO and phosphate-bu¡ered saline (PBS) were
from Gibco BRL (Cergy-pontoise, France). Foetal calf serum (FCS),
penicillin, streptomycin sulfate and glutamine were from Boehringer
Mannheim (Meylan, Claix, France). Human recombinant NGF and
hygromycin B were obtained from Sigma Chemical (L’Isle d’Abeau,
France). 35 mm dishes biocoat collagen I, culture slides biocoat col-
lagen I and T-75 £asks biocoat collagen I were from Becton Dick-
inson (Le Pont de Claix, France). The antibody against the extracel-
lular domain of P75NTR (CHEX) was kindly given by Dr L.F.
Reichardt (San Francisco, CA, USA).
2.2. Cell cultures
Human neuroblastoma SH-SY5Y cells were routinely cultured in
DMEM culture medium supplemented with 5% FCS, pyruvate Na
1 mM, anti-PPLO 5 ml, gentamicin 0.1 mg/ml and 4 mM glutamine
on pre-coated collagen T-75 £asks. Human neuroblastoma SK-N-BE
cells were cultured in RPMI 1640 culture medium supplemented with
15% FCS, 2 mM glutamine and 50 mg/ml gentamicin. SK-N-BE cells
expressing TrkA were maintained in the same medium supplemented
with 500 Wg/ml geneticin. Murine aortic smooth muscle cells (ASMCs)
were isolated from P75NTR knock-out (KO) mice or the corresponding
wild-type mice (C129-Ngfrtm1Jae) (Jackson Labs, ME, USA) [27] and
routinely cultured in DMEM culture medium supplemented with 10%
FCS, 50 U/ml penicillin, 50 Wg/ml streptomycin sulfate and 4 mM
glutamine.
2.3. Generation of neuroblastoma cells expressing TrkA
Subcon£uent human neuroblastoma SK-N-BE cells were trans-
fected with a plasmid vector carrying the cDNA of the human
TrkA gene under the control of the cytomegalovirus promoter and
the bacterial neo gene. G418 (800 Wg/ml)-resistant colonies were iso-
lated, grown and analysed for TrkA expression by a Western blot.
2.4. Measurement of apoptosis
SH-SY5Y cells were seeded in 35 mm Petri dishes biocoat collagen
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(105 cells/well) in DMEM+5% FCS and grown for 24 h. Culture
medium was then aspirated, cells were rinsed with PBS and fresh
medium+5% FCS or 0.2% FCS was added in the presence of saline
or NGF at the indicated concentrations. SK-N-BE cells were seeded
in 35 mm Petri dishes (105 cells/well) in RPMI 1640 culture me-
dium+15% FCS and grown for 24 h. Culture medium was then aspi-
rated, cells were rinsed and fresh medium+15% FCS or 0.2% FCS was
added in the presence of saline or NGF (100 ng/ml). ASMCs were
seeded in 35 mm Petri dishes in DMEM+10% FCS (5U104 cells) for
3 days in a humidi¢ed 5% CO2 incubator at 37‡C. Culture medium of
non-con£uent ASMCs was then replaced with fresh medium+10% or
0.2% FCS in the presence of saline or NGF at the indicated concen-
trations. 48 h later, apoptosis was measured with a photometric en-
zyme immunoassay (cell death detection ELISA, Boehringer Mann-
heim, Germany) for the quantitative detection of cytoplasmic histone-
associated DNA fragments (mono- and oligonucleosomes). Apoptosis
was expressed as the mean number of oligonucleosomes/105 cells þ
S.D. Results were from three di¡erent experiments performed in
triplicate.
2.5. Terminal-deoxynucleotidyltransferase-mediated dUTP-biotin nick
end labelling (TUNEL) assay
SH-SY5Y cells were seeded on biocoat collagen eight well culture
slides (5U104 cells/well) in DMEM+5% FCS and grown for 24 h.
Culture medium was then aspirated, cells were rinsed with PBS and
fresh medium+5% FCS or 0.2% FCS was added in the presence of
saline or NGF (100 ng/ml). 48 h later, the cells were rinsed two times
with PBS, ¢xed for 30 min at room temperature in a 4% paraformal-
dehyde solution, washed with PBS and incubated for 30 min at room
temperature in 0.3% hydrogen peroxide in methanol. Cells were then
rinsed twice with PBS and measurement of DNA fragmentation by
the TUNEL assay was carried out using the in situ cell death detec-
tion kit POD (Boehringer Mannheim, Germany) according to the
manufacturer’s instructions.
2.6. Immuno£uorescence staining of P75NTR
SH-SY5Y neuroblastoma cells were seeded on coverslips pre-coated
with collagen and incubated for 48 h in DMEM+5% or 0.2% FCS.
The cells were then ¢xed as described above, washed with PBS and
incubated for 30 min at room temperature in 0.3% hydrogen peroxide
in methanol. The cells were then incubated for 2 min with PBS con-
taining 0.1% triton X-100 and 0.1% sodium citrate at 4‡C, washed
three times with PBS and incubated at room temperature for 30 min
with an anti-P75NTR antibody (Promega, Charbonnie'res, France) (di-
lution 1/200) in PBS. The cells were then washed three times and
incubated for 30 min in PBS with a biotinylated secondary antibody
(rabbit anti-goat IgG) (Vector Laboratories, Burlingam, USA). Cells
were then rinsed, incubated for 30 min in avidin-HRP complex (Vec-
tastain ABC reagent, Vector Laboratories, Burlingam, USA) and de-
veloped for 5 min with the DAB substrate kit peroxidase (Vector
Laboratories, Burlingam, USA).
2.7. Flow cytometry analysis
Cells were harvested by trypsin (0.05%) EDTA (0.02%), treated
with PBS containing 2% BSA and exposed for 20 min at 0‡C to an
anti-P75NTR antibody (4 Wg/ml) (monoclonal antibody 192-IgG, Boeh-
ringer Mannheim, Germany). After three washes in PBS, the cells
were exposed for 20 min at 0‡C to a phycoerythrin-labelled antibody
(goat anti-mouse IgG) (dilution 1/50) (Immunotech, Marseille,
France) in PBS+2% BSA. The analysis was performed on a FacsStar
Plus £ow cytometer (Becton Dickinson, Paris, France). Emission £u-
orescence was measured with a DF575/26 ¢lter. Data acquisition and
analysis were performed with CellQuest software.
3. Results and discussion
3.1. Cell cycle phase-speci¢c expression of P75NTR
Although the e¡ect of NGF on cell survival has been ac-
knowledged for a long time, the exact role(s) plaid by P75NTR
in the functional response to NGF is still highly controversial
and contradictory results have been obtained. For example, in
neonatal dorsal root ganglion neurons, P75NTR appeared to
Fig. 1. Immunohistochemical detection of P75NTR on SH-SY5Y cells. SH-SY5Y cells were incubated for 48 h in culture medium containing
0.2% FCS (b) or 5% FCS (c). A blank is shown in (a). Immunohistochemical detection of P75NTR was performed as described under Section 2.
Magni¢cation: U500. On the ¢gures, the quantitative immunodetection of P75NTR is shown, determined at the cell surface by £ow cytometry.
Units are arbitrary.
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mediate a pro-apoptotic signal [28], whereas in other cell sys-
tems, NGF behaved as a pro-apoptotic factor [29,30]. In or-
der to determine if these contradictory results could be ex-
plained by a di¡erential cell cycle-dependent expression of
P75NTR at the cell surface, we have examined the e¡ect of
NGF on the apoptotic response of SH-SY5Y, a human neu-
roblastoma cell line, and evaluated the role plaid by P75NTR
in the pro-apoptotic activity of NGF. On subcon£uent SH-
SY5Y cells, under experimental conditions where the cells
were exponentially growing (in 5% FCS), the expression of
P75NTR strongly increased at the cell surface (Fig. 1c), where-
as when the cells were cultured in 0.2% FCS (quiescent cells),
a decreased expression of P75NTR could be observed (Fig. 1b).
These results are in agreement with those recently reported by
Urdiales et al. [26] on PC-12 cells.
3.2. Dual e¡ect of NGF on the apoptosis of SH-SY5Y cells
Under experimental conditions which allowed the cells to
Fig. 2. E¡ect of NGF on the apoptosis of SH-SY5Y cells. Subcon£uent monolayers of SH-SY5Y cells were incubated for 48 h in culture me-
dium containing 5% FCS (a and b) or 0.2% FCS (c and d) in the absence (a and c) or presence (b and d) of NGF (100 ng/ml). Apoptotic cells
were detected by TUNEL. Magni¢cation: U500. On the ¢gures, the quantitative determination of mono/oligonucleosomes is shown, measured
with an ELISA kit as described under Section 2 and expressed as mean number of oligonucleosomes/105 cells þ S.D. (n = 9). (e) SH-SY5Y cells
were pre-incubated for 48 h in medium containing 5% FCS (b) or 0.2% FCS (F) in the presence of increasing concentrations of NGF. Apopto-
sis was measured with an ELISA kit. Data are reported as % apoptosis compared to cells in 5% FCS (n = 9).
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proliferate and to express preferentially P75NTR, NGF at the
concentration of 100 ng/ml induced apoptosis of SH-SY5Y
cells (Fig. 2b). This pro-apoptotic e¡ect of NGF was demon-
strated by TUNEL labelling and con¢rmed by the dosage of
mono/oligonucleosomes (Fig. 2b and e). NGF induced a dose-
dependent pro-apoptotic e¡ect which was detected from the
concentration of 1 ng/ml and reached a maximum at 1 Wg/ml
(Fig. 2e). The concentration that induced a half-maximum
e¡ect (ED50) was 11.4 ng/ml. This pro-apoptotic e¡ect of
NGF was time-dependent and was signi¢cant after 18 h of
incubation (not shown). In contrast, under experimental con-
ditions where the level of P75NTR expression at the cell surface
was low (cells cultured in 0.2% FCS for 24 h), NGF at the
concentration of 10 ng/ml inhibited the apoptosis of SH-
SY5Y cells induced by FCS deprivation (Fig. 2d and e).
The dose-dependent anti-apoptotic activity of NGF was de-
tected from the concentration of 0.01 ng/ml and reached a
maximum at 10 ng/ml (Fig. 2e). The ED50 value was 0.26
ng/ml, showing that NGF was anti-apoptotic at lower doses
compared to those exhibiting a pro-apoptotic e¡ect. This dif-
ference in e⁄cacy might be due to a higher a⁄nity of NGF
for TrkA than for P75NTR as demonstrated several times on
other cell types [10^13]. These results therefore show that
NGF exhibits dual pro- or anti-apoptotic properties via
P75NTR and TrkA, respectively, and show that NGF exerts
a pro-apoptotic e¡ect on exponentially growing cells over-ex-
pressing P75NTR, whereas it exerts a potent anti-apoptotic
activity on quiescent cells when P75NTR expression is de-
creased but when TrkA expression is prevalent at the cell
surface. These results support our hypothesis that the survival
response to NGF depends on the growth state of the cells and
further extend the observations made by Urdiales et al. [26].
To study in further detail how NGF exerted a pro-apop-
totic e¡ect, we determined the e¡ect of an antibody against
the extracellular domain of P75NTR [25]. Under culture con-
ditions where P75NTR was preferentially expressed at the cell
surface (growing cells), this antibody abrogated the pro-apop-
totic e¡ect of NGF (Fig. 3). In contrast, under experimental
conditions which allowed the cells to express preferentially
TrkA (0.2% FCS), it did not block the anti-apoptotic e¡ect
of NGF (not shown). This observation therefore shows that
NGF exerts its anti-apoptotic e¡ect in a P75NTR-independent
manner and provides compelling evidence that apoptosis is a
consequence of the NGF/P75NTR interaction and that the
anti-apoptotic activity of NGF is selectively mediated by a
NGF/TrkA signalling pathway with no contribution of
P75NTR.
The ongoing dissection of the roles of P75NTR and TrkA in
NGF signalling has generated a number of apparent para-
doxes. Recent studies have suggested that TrkA alters the
conformation of P75NTR in the absence of ligand [31] and
that TrkA and P75NTR co-localise on the cell surface [32].
The synergy of P75NTR and TrkA in inducing optimal trophic
signalling has been demonstrated [33]. On the other hand, it
has been shown that P75NTR-mediated apoptosis of develop-
ing forebrain neurons was restricted to cells expressing
P75NTR but not TrkA [22]. In addition, TrkA expression
has been shown to block ligand-mediated ceramide produc-
tion induced by P75NTR [21]. These observations, consistent
with a model of mutual receptor modulation [15], led us to
examine the e¡ect of NGF on cells lacking one of the two
receptors.
In order to con¢rm that P75NTR is only involved in the pro-
apoptotic NGF signalling, we have prepared primary cultures
of ASMCs from P75NTR KO mice and from the correspond-
ing wild-types which have been shown to express both P75NTR
and TrkA at their surfaces [34]. Like in SH-SY5Y and PC-12
cells [26], this expression varied in a cell cycle phase-speci¢c
manner (not shown). Under experimental conditions which
allowed the cells to preferentially express P75NTR (cultured
in 10% FCS), NGF (100 ng/ml) exhibited a pro-apoptotic
e¡ect on ASMCs from wild-type mice but did not show any
e¡ect on ASMCs isolated from P75NTR KO mice (Table 1).
Fig. 3. E¡ect of an antibody against the extracellular domain of
P75NTR on the pro-apoptotic e¡ect of NGF on SH-SY5Y cells.
Subcon£uent monolayers of SH-SY5Y cells were incubated for 48 h
in medium containing 5% FCS with saline or the antibody against
the extracellular domain of P75NTR, in the presence (full bars) or
absence (empty bars) of NGF (100 ng/ml). Apoptosis was measured
with an ELISA kit and expressed as mean number of oligonucleo-
somes/105 cells þ S.D. (n = 9).
Table 1
E¡ect of NGF on the apoptosis of cells which do not express P75NTR
Mouse ASMCs SK-N-BE
Wild-type P753=3 Wild-type TrkA-transfected
Quiescence (0.2% FCS) Control ND ND 683 þ 30 690 þ 25
+NGF ND ND 700 þ 45 162 þ 39
Growth (10% FCS) Control 25 þ 2 39 þ 3 ND ND
+NGF 190 þ 20 50 þ 5 ND ND
Subcon£uent monolayers of ASMCs from P75NTR KO mice and from the corresponding wild-types or human neuroblastoma cells SK-N-BE
and SK-N-BE cells transfected with TrkA were pre-incubated for 48 h in culture medium containing 0.2 or 10% FCS in the absence or pres-
ence of NGF (100 ng/ml). Apoptosis was measured with an ELISA kit and expressed as mean number of oligonucleosomes/105 cells þ S.D.
(n = 9). ND = not determined.
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These results further con¢rm that NGF exerts its pro-apop-
totic e¡ect in a P75NTR manner exclusively. On the other
hand, the neuroblastoma cell line SK-N-BE was chosen to
study the TrkA-mediated survival e¡ect of NGF. On this
cell line which does not express P75NTR nor TrkA [35],
NGF did not show any pro- or anti-apoptotic activity (Table
1), but when this cell line was transfected with TrkA [35],
NGF at the concentration of 10 ng/ml presented a potent
anti-apoptotic activity suggesting that the survival response
to NGF depends on its interaction with TrkA without any
involvement of P75NTR.
These results support the hypothesis that the survival re-
sponse to NGF depends on its binding to TrkA without any
involvement of P75NTR, which in turn selectively mediates the
pro-apoptotic activity of NGF with no contribution of TrkA
and show that, depending on the growth state of the cells,
NGF exhibits dual pro- or anti-apoptotic properties via
P75NTR and TrkA, respectively.
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